Blepharophimosis, Ptosis, and Epicanthus Inversus Syndrome (BPES)

What Is It, Signs and Symptoms, Treatment, and More

Author: Anna Hernández, MD
Editor: Alyssa Haag, MD
Editor: Józia McGowan, DO
Editor: Kelsey LaFayette, DNP, ARNP, FNP-C
Illustrator: Abbey Richard, MSc
Modified: Sep 10, 2025

What is blepharophimosis, ptosis, and epicanthus inversus syndrome (BPES)?

Blepharophimosis, ptosis, and epicanthus inversus syndrome, or BPES, is a rare congenital disorder that affects the development of the eyelids and in some cases the ovaries. Individuals with this syndrome have shortened eyelids partially covering the eyes, resulting in a narrow eyelid opening. This finding is associated with ptosis, or drooping eyelids, and epicanthus inversus, which is a skin fold at the inner corner of the eye that runs inwards and upwards. 

There are two different types of BPES syndrome. BPES type I presents with all the characteristic facial features, along with premature ovarian insufficiency (POI) in genetic females. Premature ovarian insufficiency occurs when the ovaries stop ovulating and releasing sex hormones, such as estrogen and progesterone before the person is 40 years old. BPES type II, on the other hand, only presents with the characteristic facial features and has no other clinical manifestations. 

An infographic detailing BPES.

What causes BPES?

BPES is caused by mutations in the FOXL2 gene, which is located in chromosome 3. The FOXL2 gene is expressed during fetal development and is important for the embryonic development of the muscles of the eyelids and the growth and development of the ovariesMutations in the FOXL2 gene are inherited in an autosomal dominant manner, meaning that only one copy of the altered gene is needed to cause the disease. Less commonly, the condition may be caused by de novo mutations, which means they occur on their own without being inherited. 

What are the signs and symptoms of BPES?

BPES is characterized by four major facial features, including blepharophimosis, or narrowing of the eyelid opening; ptosis, or drooping eyelids; wide-set eyes; and epicanthus inversus, which is a skin fold that extends from the lower to the upper eyelid. There may also be other facial features, such as a wide nasal bridge and highly arched eyebrows. Some individuals may present with additional eye problems, such as strabismus, or misalignment of the eyes; and refractive errors like myopia and astigmatism. 

In BPES type I, individuals also have symptoms of premature ovarian insufficiency (POI), including missed or infrequent menstrual periods and/or infertility, which is defined as the inability to conceive after one year of unprotected sex. The lack of estrogen and progesterone associated with POI can cause symptoms that are similar to natural menopause, such as hot flashes, night sweats, and vaginal dryness, which can lead to pain during sex.  

How is BPES diagnosed?

Diagnosis of BPES is usually suspected clinically based on the characteristic facial features. Genetic females who develop symptoms of premature ovarian insufficiency may undergo laboratory evaluation of ovarian function with serum levels of follicle stimulating hormone (FSH), luteinizing hormone (LH), estradiol, and progesterone. Confirmation of the diagnosis can be achieved by genetic testing looking for mutations in the FOXL2 gene 

How is BPES treated?

Treatment of BPES typically involves a multidisciplinary team consisting of pediatricians, ophthalmologists, oculoplastic surgeons, and gynecologists. Management includes surgery to correct the eyelids and treatment of related vision problems. In cases where there is premature ovarian insufficiency, treatment may involve hormone replacement therapy to replace sex hormones, including estrogen and progesterone. For individuals who struggle with infertility, assisted reproductive techniques such as in-vitro fertilization (IVF) can be used. Finally, genetic counseling may be recommended to discuss the implications of the disease in the individual’s life and future pregnancies. 

What are the most important facts to know about BPES?

Blepharophimosis, ptosis, and epicanthus inversus syndrome (BPES) is a genetic condition that affects the development of the eyelids and in some cases the ovaries. It is characterized by narrowing of the eyelid opening, drooping eyelids, and a skin fold at the inner corner of the eyes. With BPES type I, individuals also experience symptoms of ovarian insufficiency, including irregular periods, infertility, hot flashes, and vaginal dryness, among others. BPES type II, on the other hand, only presents with characteristic facial features. Diagnosis is suspected clinically based on the characteristic facial features and can be confirmed by genetic testing. Treatment involves surgery to correct the eyelids and hormonal treatment of premature ovarian insufficiency, when necessary.  

References


Meduri G, Bachelot A, Duflos C, et al. FOXL2 mutations lead to different ovarian phenotypes in BPES patients: Case report. Hum Reprod. 2010;25(1):235-243. doi:10.1093/humrep/dep355 


Meng T, Zhang W, Zhang R, et al. Ovarian reserve and ART outcomes in blepharophimosis-ptosis-epicanthus inversus syndrome patients with FOXL2 mutations. Front Endocrinol (Lausanne). 2022;13. doi:10.3389/fendo.2022.829153 


Tyers AG. The blepharophimosis-ptosis-epicanthus inversus syndrome (BPES). Orbit. 2011;30(5):199-201. doi:10.3109/01676830.2010.547266